Rat NLR Family, Pyrin Domain Containing Protein 3 (NLRP3) ELISA Kit
Referência MBS2706815-96
Tamanho : 96-Strip-Wells
Marca : MyBiosource
NLR Family, Pyrin Domain Containing Protein 3 (NLRP3) ELISA Kit for Rat
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2706815SPECIAL PROMOTIONAL PRICING for a limited time
Intended Uses: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of NLRP3 in rat tissue homogenates, cell lysates, cell culture supernates and other biological fluids.Principle of the Assay: The microplate provided in this kit has… More details
Product Overview
Online Datasheet in PDFProduct Name
NLR Family, Pyrin Domain Containing Protein 3 (NLRP3), ELISA Kit
Full Product Name
Rat NLR Family, Pyrin Domain Containing Protein 3 (NLRP3) ELISA Kit
Product Gene Name
NLRP3 elisa kit
Product Synonym Names
AVP; AGTAVPRL; AII; AII/AVP; C1orf7; CIAS1; CLR1.1; FCAS; FCU; MWS; NALP3; PYPAF1; Cryopyrin; Cold Induced Autoinflammatory Syndrome 1; Caterpiller-Like Receptor 1.1
Species Reactivity
Rat
Assay Type
Quantitative Sandwich
Samples
Rat tissue homogenates, cell lysates, cell culture supernates and other biological fluids
Detection Range
0.312-20ng/mL
Sensitivity
< 0.115ng/mL
Specificity
This assay has high sensitivity and excellent specificity for detection of NLRP3. No significant cross-reactivity or interference between NLRP3 and analogues was observed.
Preparation and Storage
The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Inter-assay Precision
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level NLRP3 were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100. Inter-Assay: CV<12%
Intra-assay Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level NLRP3 were tested 20 times on one plate, respectively. Intra-Assay: CV<10%
Molecular Weight
115,968 Da
OMIM
AF410477 mRNA
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
ISO Certification
Manufactured in an ISO 9001:2008 and ISO 13485:2003 Certified Laboratory.
Product References and Citations for NLRP3 elisa kit
The therapeutic effect of Apocynin against hyperoxy and Inflammation-Induced lung injury; Int Immunopharmacol; 2021 Dec;101(Pt A):108190.; PMID: 34607228; Cuneyt Tayman; Department of Neonatology, University of Health Sciences, Ankara City Hospital, Cankaya, Ankara, Turkey. Electronic address: ctayman22@gmail.com.
Other Notes
Small volumes of NLRP3 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for NLRP3 purchase
MBS2706815 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the NLR Family, Pyrin Domain Containing Protein 3 (NLRP3) ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing NLRP3. The ELISA analytical biochemical technique of the MBS2706815 kit is based on NLRP3 antibody-NLRP3 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect NLRP3 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, NLRP3. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).
Additional Details
NCBI/Uniprot data below describe general gene information for NLRP3. It may not necessarily be applicable to this product.
NCBI Official Full Name
NLR family, pyrin domain containing 3
NCBI Official Synonym Full Names
NLR family pyrin domain containing 3
NCBI Official Symbol
NLRP3
NCBI Official Synonym Symbols
AII; AVP; FCU; MWS; FCAS; CIAS1; FCAS1; NALP3; C1orf7; CLR1.1; DFNA34; PYPAF1; AGTAVPRL
UniProt Protein Name
NACHT, LRR and PYD domains-containing protein 3
UniProt Synonym Protein Names
Angiotensin/vasopressin receptor AII/AVP-like; Caterpiller protein 1.1; CLR1.1; Cold-induced autoinflammatory syndrome 1 protein; Cryopyrin; PYRIN-containing APAF1-like protein 1
Protein Family
NACHT, LRR and PYD domains-containing protein
UniProt Gene Name
NLRP3
UniProt Synonym Gene Names
C1orf7; CIAS1; NALP3; PYPAF1; CLR1.1
NCBI Protein Information
NACHT, LRR and PYD domains-containing protein 3
NCBI Summary for NLRP3
This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NALP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, and neonatal-onset multisystem inflammatory disease (NOMID). Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Oct 2008]
Show more UniProt Comments for NLRP3
NLRP3: May function as an inducer of apoptosis. Interacts selectively with ASC and this complex may function as an upstream activator of NF-kappa-B signaling. Inhibits TNF-alpha induced activation and nuclear translocation of RELA/NF-KB p65. Also inhibits transcriptional activity of RELA. Activates caspase-1 in response to a number of triggers including bacterial or viral infection which leads to processing and release of IL1B and IL18. Defects in NLRP3 are the cause of familial cold autoinflammatory syndrome type 1 (FCAS1); also known as familial cold urticaria. FCAS are rare autosomal dominant systemic inflammatory diseases characterized by episodes of rash, arthralgia, fever and conjunctivitis after generalized exposure to cold. Defects in NLRP3 are a cause of Muckle-Wells syndrome (MWS); also known as urticaria-deafness-amyloidosis syndrome. MWS is a hereditary periodic fever syndrome characterized by fever, chronic recurrent urticaria, arthralgias, progressive sensorineural deafness, and reactive renal amyloidosis. The disease may be severe if generalized amyloidosis occurs. Defects in NLRP3 are the cause of chronic infantile neurologic cutaneous and articular syndrome (CINCA); also known as neonatal onset multisystem inflammatory disease (NOMID). CINCA is a rare congenital inflammatory disorder characterized by a triad of neonatal onset of cutaneous symptoms, chronic meningitis and joint manifestations with recurrent fever and inflammation. Belongs to the NLRP family. 5 isoforms of the human protein are produced by alternative splicing.
Protein type: Inhibitor
Chromosomal Location of Human Ortholog: 1q44
Cellular Component: cytoplasm; cytosol; endoplasmic reticulum; extracellular region; NLRP3 inflammasome complex; nucleus
Molecular Function: ATP binding; identical protein binding; peptidoglycan binding; protein binding; sequence-specific DNA binding; transcription factor binding
Biological Process: activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptosis; cytokine secretion involved in immune response; defense response; defense response to Gram-positive bacterium; defense response to virus; detection of biotic stimulus; inflammatory response; innate immune response; interleukin-1 beta production; interleukin-1 secretion; interleukin-18 production; negative regulation of acute inflammatory response; negative regulation of inflammatory response; negative regulation of interleukin-1 beta secretion; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; NLRP3 inflammasome complex assembly; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interleukin-1 beta secretion; positive regulation of interleukin-13 production; positive regulation of interleukin-4 production; positive regulation of interleukin-5 production; positive regulation of NF-kappaB transcription factor activity; positive regulation of T-helper 17 cell differentiation; positive regulation of T-helper 2 cell cytokine production; positive regulation of T-helper 2 cell differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of type 2 immune response; protein deubiquitination; protein oligomerization; signal transduction; transcription, DNA-dependent
Disease: Cinca Syndrome; Deafness, Autosomal Dominant 34, With Or Without Inflammation; Familial Cold Autoinflammatory Syndrome 1; Muckle-wells Syndrome
Show more Protein type: Inhibitor
Chromosomal Location of Human Ortholog: 1q44
Cellular Component: cytoplasm; cytosol; endoplasmic reticulum; extracellular region; NLRP3 inflammasome complex; nucleus
Molecular Function: ATP binding; identical protein binding; peptidoglycan binding; protein binding; sequence-specific DNA binding; transcription factor binding
Biological Process: activation of cysteine-type endopeptidase activity involved in apoptotic process; apoptosis; cytokine secretion involved in immune response; defense response; defense response to Gram-positive bacterium; defense response to virus; detection of biotic stimulus; inflammatory response; innate immune response; interleukin-1 beta production; interleukin-1 secretion; interleukin-18 production; negative regulation of acute inflammatory response; negative regulation of inflammatory response; negative regulation of interleukin-1 beta secretion; negative regulation of NF-kappaB import into nucleus; negative regulation of NF-kappaB transcription factor activity; NLRP3 inflammasome complex assembly; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; positive regulation of interleukin-1 beta secretion; positive regulation of interleukin-13 production; positive regulation of interleukin-4 production; positive regulation of interleukin-5 production; positive regulation of NF-kappaB transcription factor activity; positive regulation of T-helper 17 cell differentiation; positive regulation of T-helper 2 cell cytokine production; positive regulation of T-helper 2 cell differentiation; positive regulation of transcription from RNA polymerase II promoter; positive regulation of type 2 immune response; protein deubiquitination; protein oligomerization; signal transduction; transcription, DNA-dependent
Disease: Cinca Syndrome; Deafness, Autosomal Dominant 34, With Or Without Inflammation; Familial Cold Autoinflammatory Syndrome 1; Muckle-wells Syndrome
Research Articles on NLRP3
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Pathways associated with NLRP3 elisa kit
| Products by Pathway | Pathway Diagram |
|---|---|
| Immune System Pathway antibodies | Immune System Pathway Diagram |
| Inflammasomes Pathway antibodies | Inflammasomes Pathway Diagram |
| Influenza A Pathway antibodies | Influenza A Pathway Diagram |
| Influenza A Pathway antibodies | Influenza A Pathway Diagram |
| Innate Immune System Pathway antibodies | Innate Immune System Pathway Diagram |
| NOD Pathway antibodies | NOD Pathway Diagram |
| NOD-like Receptor Signaling Pathway antibodies | NOD-like Receptor Signaling Pathway Diagram |
| NOD-like Receptor Signaling Pathway antibodies | NOD-like Receptor Signaling Pathway Diagram |
| Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways antibodies | Nucleotide-binding Domain, Leucine Rich Repeat Containing Receptor (NLR) Signaling Pathways Diagram |
| Pertussis Pathway antibodies | Pertussis Pathway Diagram |
Diseases associated with NLRP3 elisa kit
| Disease Name | Pubmed Publications |
|---|---|
| Inflammation Antibodies | >833 publications with NLRP3 and Inflammation |
| MUCKLE-WELLS SYNDROME Antibodies | >178 publications with NLRP3 and MUCKLE-WELLS SYNDROME |
| Necrosis Antibodies | >168 publications with NLRP3 and Necrosis |
| Cryopyrin-Associated Periodic Syndromes Antibodies | >131 publications with NLRP3 and Cryopyrin-Associated Periodic Syndromes |
| FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1 Antibodies | >129 publications with NLRP3 and FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1 |
| Disease Models, Animal Antibodies | >103 publications with NLRP3 and Disease Models, Animal |
| Cardiovascular Diseases Antibodies | >85 publications with NLRP3 and Cardiovascular Diseases |
| Lung Diseases Antibodies | >73 publications with NLRP3 and Lung Diseases |
| Fibrosis Antibodies | >56 publications with NLRP3 and Fibrosis |
| Diabetes Mellitus Antibodies | >45 publications with NLRP3 and Diabetes Mellitus |
Organs/Tissues associated with NLRP3 elisa kit
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >362 publications with NLRP3 and Blood |
| Lung Antibodies | >116 publications with NLRP3 and Lung |
| Bone Marrow Antibodies | >98 publications with NLRP3 and Bone Marrow |
| Brain Antibodies | >62 publications with NLRP3 and Brain |
| Intestine Antibodies | >26 publications with NLRP3 and Intestine |
| Connective Tissue Antibodies | >24 publications with NLRP3 and Connective Tissue |
| Pancreas Antibodies | >16 publications with NLRP3 and Pancreas |
| Thymus Antibodies | >3 publications with NLRP3 and Thymus |
| Prostate Antibodies | >2 publications with NLRP3 and Prostate |


